Harold Davidson & Associates Inc. logo

Harold Davidson & Associates Inc. Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Harold Davidson & Associates Inc. with $220.1M in long positions as of Q3 2025, 52% allocated to Technology, and 62% concentrated in top 10 positions.

Portfolio Value
$220.1M
Top 10 Concentration
62%
Top Sector
Technology (52%)
US Exposure
99%
Market Cap Focus
Mega Cap
Countries
2

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Technology: 52.00%TechnologyFinancial Services: 12.90%Financial ServicesConsumer Cyclical: 10.70%Consumer CyclicalIndustrials: 8.80%IndustrialsHealthcare: 5.20%Communication Services: 4.90%Consumer Defensive: 3.00%Utilities: 1.20%Energy: 0.90%ETF: 0.40%
Technology
52.00%
Financial Services
12.90%
Consumer Cyclical
10.70%
Industrials
8.80%
Healthcare
5.20%
Communication Services
4.90%
Consumer Defensive
3.00%
Utilities
1.20%
Energy
0.90%
ETF
0.40%

Industry Breakdown

37 industries across all sectors

Consumer Electronics: 23.55%Consumer ElectronicsSoftware - Infrastructure: 14.88%Software - InfrastructureCommunication Equipment: 8.72%Communication EquipmentFinancial - Credit Services: 6.27%Internet Content & Information: 4.33%Aerospace & Defense: 4.30%Banks - Diversified: 4.10%Semiconductors: 3.58%Home Improvement: 2.96%Drug Manufacturers - General: 2.95%Discount Stores: 2.43%Specialty Retail: 2.25%25 more: 19.69%25 more
Consumer Electronics
Technology
23.55%
Software - Infrastructure
Technology
14.88%
Communication Equipment
Technology
8.72%
Financial - Credit Services
Financial Services
6.27%
Internet Content & Information
Communication Services
4.33%
Aerospace & Defense
Industrials
4.30%
Banks - Diversified
Financial Services
4.10%
Semiconductors
Technology
3.58%
Home Improvement
Consumer Cyclical
2.96%
Drug Manufacturers - General
Healthcare
2.95%
Discount Stores
Consumer Defensive
2.43%
Specialty Retail
Consumer Cyclical
2.25%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mega Cap (> $200B): 79.40%Mega Cap (> $200B)Large Cap ($10B - $200B): 19.94%Large Cap ($10B - $200B)Mid Cap ($2B - $10B): 0.09%Micro Cap ($50M - $300M): 0.17%N/A (ETF or Unknown): 0.40%
Mega Cap (> $200B)
79.40%
Large Cap ($10B - $200B)
19.94%
Mid Cap ($2B - $10B)
0.09%
Micro Cap ($50M - $300M)
0.17%
N/A (ETF or Unknown)
0.40%

Portfolio Concentration

Top 10 Holdings %
61.92%
Top 20 Holdings %
78.61%
Top 50 Holdings %
97.67%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
99.39%
International
0.614%
Countries
2
Largest Int'l Market
Switzerland - 0.61%
United States of America
99.39% ($218.7M)
64 holdings
Switzerland
0.61% ($1.4M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
3 quarters
Avg. Top 20
2.9 quarters
Avg. All Positions
2.6 quarters
Median Holding Period
3 quarters
Persistence Rate
-
Persistent Holdings Weight
-
Persistent Positions
0
Longest Held
Lowe's Companies Inc. logo
Lowe's Companies Inc.LOW - 3 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.37%
Avg. Position Weight
1.54%
Largest Position
Apple Inc. logo
Apple Inc.AAPL - 23.55%
Largest Ownership Stake
Allogene Therapeutics, Inc. Common Stock logo
Allogene Therapeutics, Inc. Common StockALLO - 0.13%
Avg. Ownership Stake
0.002%
Ownership Stake >5%
0
Ownership Stake >1%
0

Historical (Since Q4 2024)

Avg. New Position
1.37%
Avg. Ownership Stake
0.002%
Largest Position
Apple Inc. logo
Apple Inc.AAPL - 25.01% (Q4 2024)
Largest Ownership Stake
Allogene Therapeutics, Inc. Common Stock logo
Allogene Therapeutics, Inc. Common StockALLO - 0.13% (Q3 2025)

Portfolio Turnover

Current Quarter

Turnover Ratio
13.3%
Value Traded
$29.26M
Positions Added
5
Positions Exited
3

Historical (Since Q4 2024)

Avg. Turnover Ratio
21.2%
Avg. Positions Added
19
Avg. Positions Exited
3
Highest Turnover
50.0%
Q4 2024
Lowest Turnover
5.1%
Q1 2025

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.